 NEW YORK LONDON PARIS--BUSINESS WIRE-- biopharmaceutical--Regulatory News: Aptorum Group Limited NASDAQ: APM, Euronext Paris: APM, a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChip Money Report on Bloomberg TV Oct. 16 at 7 p.m. Eastern Time ET. To view the interview segment, please visit: About Aptorum Group Limited Aptor 